Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business1 February 2016Corporate and M&A Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryBeyond New York and London: the must-have locations for the global eliteTraitors and Big Brother producers recruit top firms for major media mergerSullivan & Cromwell continues London finance build with another hire from WeilFreshfields takes headline role on £575m Telegraph acquisitionDLA Piper and Proskauer lead on BrewDog’s sale to US cannabis and drinks manufacturerPaul Hastings hires London M&A partner from Slaughter and MayRevolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesFive partners vie to succeed Hoyland as Simmons managing partner‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetry